In-hospital death in patients with acute COVID-19 was more likely in those with RV dysfunction or dilation, and more likely than in patients with other respiratory diseases, in an observational study.
A new analysis suggests that the pandemic has been devastating for the South Asian population in the greater Toronto area, which had a seropositivity rate of 24%.
Sabizabulin more than halved the risk for death compared with placebo in high-risk, hospitalized adults with COVID-19; the drug company is seeking emergency use okay.
The findings of a randomized, placebo-controlled trial of 963 patients throw into doubt the use of vitamin C for people with sepsis. In organ dysfunction, the treatment did worse than placebo.